Daniel C. Bensen

601 total citations
7 papers, 366 citations indexed

About

Daniel C. Bensen is a scholar working on Molecular Biology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Daniel C. Bensen has authored 7 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Molecular Medicine and 2 papers in Infectious Diseases. Recurrent topics in Daniel C. Bensen's work include Cancer therapeutics and mechanisms (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Protein Kinase Regulation and GTPase Signaling (1 paper). Daniel C. Bensen is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Protein Kinase Regulation and GTPase Signaling (1 paper). Daniel C. Bensen collaborates with scholars based in United States. Daniel C. Bensen's co-authors include Ronald V. Swanson, Mark L. Cunningham, Karen Joy Shaw, Kirk Nelson, Bryan P. Kwan, L. Aravind, Edward F. DeLong, Lance T. Taylor, Robert A. Feldman and Oded Béjà and has published in prestigious journals such as Applied and Environmental Microbiology, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Daniel C. Bensen

7 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel C. Bensen United States 7 274 126 78 66 44 7 366
Asfia Qureshi United States 14 198 0.7× 38 0.3× 112 1.4× 11 0.2× 15 0.3× 25 525
Nils Böhringer Germany 13 167 0.6× 63 0.5× 27 0.3× 44 0.7× 11 0.3× 22 415
Kenichi Mochida Japan 10 186 0.7× 32 0.3× 82 1.1× 40 0.6× 7 0.2× 33 348
Nadine Merkley Canada 9 201 0.7× 15 0.1× 71 0.9× 6 0.1× 15 0.3× 18 371
Yanxiang Shi United States 6 503 1.8× 62 0.5× 70 0.9× 9 0.1× 11 0.3× 7 627
Filipa V. Sena Portugal 10 248 0.9× 30 0.2× 27 0.3× 9 0.1× 9 0.2× 16 337
Julio Ng United States 6 373 1.4× 60 0.5× 35 0.4× 12 0.2× 2 0.0× 7 557
Bogdan Tokovenko Germany 14 433 1.6× 74 0.6× 85 1.1× 6 0.1× 12 0.3× 26 626
Lionel Cladière France 7 239 0.9× 68 0.5× 12 0.2× 11 0.2× 8 0.2× 10 300
Thomas Booth United Kingdom 12 250 0.9× 46 0.4× 55 0.7× 7 0.1× 4 0.1× 29 481

Countries citing papers authored by Daniel C. Bensen

Since Specialization
Citations

This map shows the geographic impact of Daniel C. Bensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel C. Bensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel C. Bensen more than expected).

Fields of papers citing papers by Daniel C. Bensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel C. Bensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel C. Bensen. The network helps show where Daniel C. Bensen may publish in the future.

Co-authorship network of co-authors of Daniel C. Bensen

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel C. Bensen. A scholar is included among the top collaborators of Daniel C. Bensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel C. Bensen. Daniel C. Bensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Hudkins, Robert L., Eric Allen, Isaac Hoffman, et al.. (2024). Discovery of TYRA-300: First Oral Selective FGFR3 Inhibitor for the Treatment of Urothelial Cancers and Achondroplasia. Journal of Medicinal Chemistry. 67(18). 16737–16756. 10 indexed citations
2.
Cunningham, Mark L., Bryan P. Kwan, Kirk Nelson, Daniel C. Bensen, & Karen Joy Shaw. (2013). Distinguishing On-Target versus Off-Target Activity in Early Antibacterial Drug Discovery Using a Macromolecular Synthesis Assay. SLAS DISCOVERY. 18(9). 1018–1026. 31 indexed citations
3.
Bensen, Daniel C., Xiaoming Li, Zhiyong Chen, et al.. (2012). Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE), Part II: Development of inhibitors with broad spectrum, Gram-negative antibacterial activity. Bioorganic & Medicinal Chemistry Letters. 23(5). 1537–1543. 58 indexed citations
4.
Bensen, Daniel C., et al.. (2012). Structure of MurA (UDP-N-acetylglucosamine enolpyruvyl transferase) fromVibrio fischeriin complex with substrate UDP-N-acetylglucosamine and the drug fosfomycin. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 68(4). 382–385. 18 indexed citations
5.
Tari, Leslie W., Michael Trzoss, Daniel C. Bensen, et al.. (2012). Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE). Part I: Structure guided discovery and optimization of dual targeting agents with potent, broad-spectrum enzymatic activity. Bioorganic & Medicinal Chemistry Letters. 23(5). 1529–1536. 88 indexed citations
6.
Tari, Leslie W., Isaac Hoffman, Daniel C. Bensen, et al.. (2006). Structural basis for the inhibition of Aurora A kinase by a novel class of high affinity disubstituted pyrimidine inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(3). 688–691. 29 indexed citations
7.
Béjà, Oded, Eugene V. Koonin, L. Aravind, et al.. (2002). Comparative Genomic Analysis of Archaeal Genotypic Variants in a Single Population and in Two Different Oceanic Provinces. Applied and Environmental Microbiology. 68(1). 335–345. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Asfia Qureshi Breakdown of academic impact, for papers by Nils Böhringer Breakdown of academic impact, for papers by Kenichi Mochida Breakdown of academic impact, for papers by Nadine Merkley Breakdown of academic impact, for papers by Yanxiang Shi Breakdown of academic impact, for papers by Filipa V. Sena Breakdown of academic impact, for papers by Julio Ng Breakdown of academic impact, for papers by Bogdan Tokovenko Breakdown of academic impact, for papers by Lionel Cladière Breakdown of academic impact, for papers by Thomas Booth
Rankless by CCL
2026